Background. Patients who have chest pain without electrocardiographic ST elevation are not candidates for thrombolytic therapy in most clinical trials. This study examined the value of technetium-99m-Sestamibi tomographic imaging to assess myocardial perfusion in patients during chest pain without ST elevation.
Methods and Results. Tc-99m-Sestamibi was injected in 14 patients who had chest pain without ST elevation, who subsequently developed enzymatic evidence of myocardial infarction within 24 hours. Tomographic imaging was performed 1-6 hours after injection. Thirteen of 14 patients showed significant perfusion defects indicative of acute myocardial infarction consistent with absent perfusion (20±15% of the left ventricle; range, 2-53%); one patient had normal images. Because of the absence of definitive electrocardiographic changes, only five patients received reperfusion therapy within 6 hours of the onset of chest pain. Regional wall motion abnormalities were present in nine of nine patients undergoing contrast ventriculography and correlated with the location of the Tc-99m-Sestamibi perfusion defect. At the time of subsequent coronary angiography, total arterial occlusion was present in 11 of the 14 patients. The infarct-related artery could be identified in 13 of the 14 patients. In six of these 13 patients, the left circumflex was the infarct-related artery.
Conclusions injected intravenously in all patients during acute chest pain before the initiation of any reperfusion therapy.13 Tomographic radionuclide images were obtained 1-6 hours later with a rotating gamma camera. Thirty images were acquired for 40 seconds each over a 1800 arc, beginning at the 450 right anterior oblique angle and ending at the left posterior oblique angle. These images were processed as previously described.1314 Quantification of the perfusion defect as a percentage of the left ventricle was performed with a five-slice modification of a previously described three-slice method.18 This method, which identifies the percentage of the left ventricle with absent perfusion, has been shown to agree closely with pathological infarct size in animal models of permanent occlusion.19,20 The five-slice method incorporates two additional slices to the previously described apical, midventricular, and basal slices (one slice midway between the apex and the midventricle and a second slice midway between the midventricle and the base) in an attempt to minimize undersampling of the left ventricle. The location of a perfusion defect was assigned by use of the 14-segment left ventricular short-axis model previously described by this institution.2' Coronary Angiography
All patients underwent coronary angiography during hospitalization (median, 3.8 hours; range, 1 hour to 5 days). The infarct-related artery was identified by analysis of the contrast ventriculogram and the coronary arteriogram and was determined to be occluded or patent according to established criteria.5 In one patient with multiple stenoses and prior infarction, the infarctrelated artery could not be confidently identified. Collateral circulation to the infarct-related vessel was classified as present or absent. Regional Wall Motion Analysis
Regional wall motion abnormalities were graded qualitatively by biplane contrast (nine patients; six studied acutely). The site of wall motion abnormality was described as apical, inferior, lateral, or anterior.
Statistical Analysis
Data are presented as mean±SD or as median and range.
Results
The study population consisted of 10 male and four female patients (age range, 46-83 years), four of whom had a history of prior myocardial infarction (Table 1) . Nine patients had chest pain of less than 6 hours in duration, six of whom had 99mTc-Sestamibi images obtained and interpreted within 6 hours from the onset of chest pain. The 
Coronary Angiography
Nine patients had undergone angiography within 6 hours from the onset of chest pain; all of these patients had total coronary artery occlusions ( Table  1) . The remaining five patients had undergone angiography later in their hospital course; two of the patients had total coronary artery occlusions. Thus, a total of 11 patients had documented coronary artery occlusion. The infarct-related vessel was the left circumflex artery in six patients, the left anterior descending coronary artery in three patients, the right coronary artery in one patient, a saphenous vein graft in three patients, and was indeterminant due to multiple vessel total occlusions in one patient. Collateral circulation to the infarct-related artery was present in five patients ( those in whom the infarct-related artery was identified) is clearly larger than reported in patients with ST elevation (8%). 24 In those patients with abnormal images indicating acute myocardial infarction, the perfusion defect location correlated with the assumed territory of the infarct-related artery and regional wall motion, when available. We did not attempt to correlate myocardium at risk and CPK enzyme levels in this small group because of the use of acute reperfusion therapy in four patients and the presence of prior myocardial infarction in an additional two patients.
Limitations
This study considered a selected group of patients with nondiagnostic electrocardiograms and subsequent positive enzymes for acute myocardial infarction. All patients with chest pain and nondiagnostic electrocardiograms during this period were not injected with 99mTc-Sestamibi. Therefore, the clinical suspicion of significant coronary artery disease was increased in these patients. Our results may not apply to all patients without ST elevation who develop non-Q wave infarction. However, these results suggest that at least a subset of such patients have significant myocardium at risk that can be identified by this technique quickly enough to allow the initiation of reperfusion therapy.
The quantitative technique used here has a number of limitations that have been described previously.'3 These include reduced accuracy and sensitivity for defects involving 5% or less of the left ventricle, which occurred in three patients in this group (two with measurable defects and one without). The study group included four patients with prior myocardial infarction, which will increase perfusion defect size. This may lead to overestimation of viable myocardium at risk because this technique cannot distinguish myocardial scar from myocardium at risk. The mean defect size was similar, however, when patients with prior myocardial infarction were excluded from analysis.
Radionuclide imaging with 99mTc-Sestamibi may be of benefit in evaluating patients with chest pain suggestive of myocardial infarction but without electrocardiographic ST elevation. The presence of significant myocardium at risk may identify patients who will benefit from acute reperfusion therapy. Further studies are needed to evaluate this possibility.
